Results 61 to 70 of about 39,848 (225)
Patient-tailored stent: Are we there yet?
Cardiology JournalPercutaneous coronary intervention (PCI) has become a routine revascularization strategy. Percutaneous coronary intervention outcome is affected by patient- and procedure-related factors.
Piotr Arski +5 more
doaj +1 more source
Left Main Stem Perforation: Management Strategies in a Potentially Catastrophic Event
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Left main stem coronary perforation is a potentially fatal complication of percutaneous coronary intervention if not recognized early and treated emergently. Treating left main stem perforation can be challenging due to the significant hemodynamic effect of one of the important steps, namely balloon tamponade.
Hilal Khan +3 more
wiley +1 more source
Long-term effectiveness and safety of sirolimus drug-eluting stents
Medical Devices: Evidence and Research, 2011 Mahesh Bikkina, Jayanth KoneruSt Joseph Regional Medical Center, Paterson, Seton Hall University, NJ, USAAbstract: The root cause of coronary artery disease is atherosclerosis, ie, intraluminal narrowing (stenosis) of the arteries that supply blood to ...
Bikkina M, Koneru J
doaj
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
SAGE Open Medical Case Reports, 2016 Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan +2 more
doaj +1 more source
Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
Journal of Cardiothoracic Surgery, 2022 Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its superiority over BMS in every aspect from restenosis rate to late lumen loss. The
Sadia Hassan +2 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Neonates with infracardiac total anomalous pulmonary venous connection (TAPVC) frequently require urgent treatment. If surgical repair is contraindicated due to extreme prematurity, interventional stenting of the ductus venosus (DV) has been introduced successfully to postpone surgery.
Simon Schmid +4 more
wiley +1 more source
Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
Clinical Medicine Insights: Cardiology, 2013 Everolimus-eluting stents (EES) represent the next generation of drug-eluting stents (DES). Important design modifications include thin strut stent backbones, less inflammatory and more biocompatible polymers, and lower drug dosing.
Matthew G. Whitbeck, Robert J. Applegate
doaj +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT This study aimed to evaluate the hemodynamic significance of in‐stent restenosis (ISR) by using a combined anatomical‐functional approach with photon‐counting CT coronary angiography (APEX‐CT CTA) and dynamic CT myocardial perfusion imaging (CT‐MPI). We prospectively enrolled 239 symptomatic patients at least 9 months after PCI.
Liang‐Shi Wang +6 more
wiley +1 more source
Revista Colombiana de Cardiología, 2012 Introducción y objetivos: los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los
Jorge A Arroyave C, Magda C Cepeda G
doaj
BMC Cardiovascular Disorders, 2022 Background Coronary artery aneurysms after drug eluting stents are rare. We present a case series of type II coronary aneurysms after implantation of Everolimus eluting stents including patients developing giant aneurysms with a toxic course.
Raghav Sharma +2 more
doaj +1 more source